Sign in

CIK 0001576885 · <br>Emerging growth company

Acumen Pharmaceuticals, Inc.

Sign in to watch
Ticker
ABOS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364108129
Phone
617-344-4190
Business address
1210-1220 WASHINGTON STREET, SUITE 210, NEWTON, MA, 02465
  1. 4 Grant or award Director acquired 35,500 shares (grant or award)
  2. 4 Grant or award Director acquired 35,500 shares (grant or award)
  3. 4 Grant or award Director acquired 35,500 shares (grant or award)
  4. 4 Grant or award Director acquired 35,500 shares (grant or award)
  5. 4 Grant or award Director acquired 35,500 shares (grant or award)
  6. 4 Grant or award Director acquired 35,500 shares (grant or award)
  7. 8-K Event Shareholder vote results
  8. 10-Q Report Quarterly Report
  9. 8-K Event Results of operations · Regulation FD disclosure
  10. ARS Other Annual Report to Security Holders
  11. DEFA14A Proxy Proxy Materials
  12. DEF 14A Proxy Proxy Statement
  13. SCHEDULE 13G Stake Statement of Beneficial Ownership
  14. EFFECT Other Notice of Effectiveness
  15. 424B3 Offering Prospectus
  16. CORRESP Other Correspondence Between Filers and SEC Staff
  17. UPLOAD Other SEC-generated Letter
  18. S-3 Offering Registration Statement
  19. S-8 Other Securities Offered to Employees in Benefit Plans
  20. 10-K Report Annual Report

Page 2 of 19 · 365 filings